Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Zhenli Li"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundImmune checkpoint inhibitor-associated myocarditis (ICI myocarditis) is an infrequent but potentially fatal immune-related adverse event. This study aimed to identify valuable indicators for risk prediction and evaluation of disease severit
Externí odkaz:
https://doaj.org/article/d263b261d8b54bfdb26212462993af10
Autor:
Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiaolong Liu
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 5, Pp 1193-1219 (2024)
Abstract Radiotherapy (RT) has been reported to induce abscopal effect in advanced hepatocellular carcinoma (HCC), but such phenomenon was only observed in sporadic cases. Here, we demonstrated that subcutaneous administration of Toll-like receptor 3
Externí odkaz:
https://doaj.org/article/bcba5366feb043319a556460d8015150
Publikováno v:
SAGE Open. Apr-Jun2024, Vol. 14 Issue 2, p1-15. 15p.
Autor:
Aixian Zheng, Zhaoyu Ning, Xiaorong Wang, Zhenli Li, Yupeng Sun, Ming Wu, Da Zhang, Xiaolong Liu, Jianwu Chen, Yongyi Zeng
Publikováno v:
Materials Today Bio, Vol 25, Iss , Pp 100955- (2024)
Tumor vaccines are emerging as one of the most promising therapeutic strategies for cancer treatment. With the advantages of low toxicity, convenient production and stable quality control, peptide vaccines have been widely used in preclinical and cli
Externí odkaz:
https://doaj.org/article/4e2f3ea281774cfea990d1bd034f5622
Publikováno v:
Frontiers in Psychology, Vol 15 (2024)
BackgroundIn the rapidly evolving digital landscape, the role of middle managers in organizational structures and processes is increasingly pivotal. Positioned at the nexus of strategic directives and operational execution, they play an important rol
Externí odkaz:
https://doaj.org/article/49cfb5551f64498e9ad25ad1d778e29e
Autor:
Geng Chen, Fang Peng, Xiuqing Dong, Zhixiong Cai, Zhenli Li, Lei He, Jinpan Hu, Xiaoxu Deng, Yutong Guo, Liman Qiu, Yang Zhou, Jingfeng Liu, Huqin Zhang, Xiaolong Liu
Publikováno v:
Molecular Oncology, Vol 17, Iss 9, Pp 1871-1883 (2023)
To overcome the dependency of strategies utilizing cell‐free DNA (cfDNA) on tissue sampling, the emergence of sequencing panels for non‐invasive mutation screening was promoted. However, cfDNA sequencing with panels still suffers from either inac
Externí odkaz:
https://doaj.org/article/0863433d1f6f49e4a4ace1601c1da413
Autor:
Ming Wu, Zijin Luo, Zhixiong Cai, Qianqian Mao, Zhenli Li, Hao Li, Cao Zhang, Yuting Zhang, Aoxue Zhong, Liming Wu, Xiaolong Liu
Publikováno v:
EMBO Molecular Medicine, Vol 15, Iss 10, Pp n/a-n/a (2023)
Abstract Neoantigens are emerging as attractive targets to develop personalized cancer vaccines, but their immunization efficacy is severely hampered by their restricted accessibility to lymphoid tissues where immune responses are initiated. Leveragi
Externí odkaz:
https://doaj.org/article/cb4262d4448542fb813c862ef5b9f426
Autor:
Lei He, Liman Qiu, Feng Chen, Tingting Chen, Fang Peng, Zhenli Li, Xiuqing Dong, Zhixiong Cai, Yuanchang Fang, Hengkai Chen, Geng Chen, Xiaolong Liu
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3578-3591 (2022)
Abstract CircRNAs have been reported to play crucial roles in tumor progression and recurrence, showing potential as biomarkers in cancer. However, the global abundance of circRNA and their involvement in hepatocellular carcinoma (HCC) development ha
Externí odkaz:
https://doaj.org/article/8610ca6fc9224649908793c174455622
Autor:
Xiuqing Dong, Geng Chen, Xinghui Huang, Zhenli Li, Fang Peng, Hengkai Chen, Yang Zhou, Lei He, Liman Qiu, Zhixiong Cai, Jingfeng Liu, Xiaolong Liu
Publikováno v:
Molecular Oncology, Vol 16, Iss 10, Pp 1986-1999 (2022)
Transarterial chemoembolization (TACE) is the most commonly used treatment for advanced hepatocellular carcinoma (HCC), but still lacks accurate real‐time biomarkers for monitoring its therapeutic efficacy. Here, we explored whether copy number pro
Externí odkaz:
https://doaj.org/article/8893ad5754d04a2ba053f292c11a22e3
Autor:
Zhixiong Cai, Xiaoping Su, Liman Qiu, Zhenli Li, Xiaolou Li, Xiuqing Dong, Fuqun Wei, Yang Zhou, Liuping Luo, Geng Chen, Hengkai Chen, Yingchao Wang, Yongyi Zeng, Xiaolong Liu
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background Clinically, prophylactic anti-recurrence treatments for hepatocellular carcinoma (HCC) patients after radical surgery are extremely limited. Neoantigen based vaccine can generate robust anti-tumor immune response in several solid
Externí odkaz:
https://doaj.org/article/79c94f7bdc2b4b8c90d4ebcaf5800121